Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZFAND4 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | KIF2B | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | NEO1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | USP2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | PLXNB3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | LSM8 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | GPAA1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | MGST2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | TNFRSF8 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | ATP6V0E1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |